Drug Shortages — A Critical Challenge for the Generic-Drug Market

Abstract

To address the growing U.S. shortages of critical generic drugs, long-term remedies, both legislative and regulatory, must be considered. Some basic changes in generic-drug law and FDA practices and greater financial incentives for manufacturing generics may be key.

Cite this work

No public copy is stored for this record, so only the metadata is cited.

Stored only when both papers are in the corpus — 99 citations exist upstream.